Insulin resistance predicts mortality in nondiabetic individuals in the U.S

Diabetes Care

Volumn 33, Issue 6, 2010, Pages 1179-1185

  Ausk, Karlee J ^a   Boyko, Edward J ^b   Ioannou, George N ^a,c  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; INSULIN;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CROSS-SECTIONAL STUDY; DEATH CERTIFICATE; DIASTOLIC BLOOD PRESSURE; EDUCATIONAL STATUS; ETHNICITY; FEMALE; FOLLOW UP; HUMAN; INSULIN RESISTANCE; MALE; MORTALITY; NATIONAL HEALTH SERVICE; OUTCOME ASSESSMENT; PHYSICAL ACTIVITY; PREDICTION; SMOKING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; UNITED STATES; WAIST HIP RATIO; BLOOD; CARDIOVASCULAR DISEASE; GLUCOSE BLOOD LEVEL; METABOLISM; MIDDLE AGED; NEOPLASM; PHYSIOLOGY;

ADULT; BLOOD GLUCOSE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; MORTALITY; NEOPLASMS; UNITED STATES;

EID: 77956076667     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc09-2110     Document Type: Article

References (25)

1. Tenenbaum A, Adler Y, Boyko V, Tenenbaum H, Fisman EZ, Tanne D, Lapidot M, Schwammenthal E, Feinberg MS, Matas Z, Motro M, Behar S. Insulin resistance is associated with increased risk of major cardiovascular events in patients with preexisting coronary artery disease. Am Heart J 2007;153:559-565 (Pubitemid 46454251)
2. Pollare T, Lithell H, Berne C. Insulin resistance is a characteristic feature of primary hypertension independent of obesity. Metabolism 1990;39:167-174 (Pubitemid 20053276)
3. Atabek ME, Pirgon O, Kivrak AS. Evidence for association between insulin resistance and premature carotid atherosclerosis in childhood obesity. Pediatr Res 2007;61:345-349
4. Pande R, Perlstein TS, Beckman JA, Creager MA. Association of insulin resistance and inflammation with peripheral arterial disease: the National Health and Nutrition Examination Survey, 1999 to 2004. Circulation 2008;118:33-41
5. Ingelsson E, Sundstrom J, Arnlov J, Zethelius B, Lind L. Insulin resistance and risk of congestive heart failure. JAMA 2005;294:334-341 (Pubitemid 41043777)
6. Bugianesi E, Gastaldelli A, Vanni E, Gambino R, Cassader M, Baldi S, Ponti V, Pagano G, Ferrannini E, Rizzetto M. Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms. Diabetologia 2005;48:634-642
7. Bloomgarden Z. Topics in type 2 diabetes and insulin resistance (Perspectives on the News). Diabetes Care 2009;32:e13-e19
8. Rezzonico J, Rezzonico M, Pusiol E, Pitoia F, Niepomniszcze H. Increased prevalence of insulin resistance in patients with differentiated thyroid carcinoma. Metab Syndr Relat Disord 2009;7:375-380
9. Eddy D, Schlessinger L, Kahn R, Peskin B, Schiebinger R. Relationship of insulin resistance and related metabolic variables to coronary artery disease: a mathematical analysis. Diabetes Care 2009;32:361-366
10. Hayashi T, Boyko EJ, McNeely MJ, Leonetti DL, Kahn SE, Fujimoto WY. Visceral adiposity, not abdominal subcutaneous fat area, is associated with an increase in future insulin resistance in Japanese Americans. Diabetes 2008;57:1269-1275
11. Matthews D, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419 (Pubitemid 15018832)
12. Wallace T, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care 2004;27:1487-1495
13. National Center for Health Statistics. Plan and Operation of the Third National Health and Nutrition Examination Survey, 1988-1994. Hyattsville, MD, U.S. Department of Health and Human Services, Public Health Services, Centers for Disease Control and Prevention, 1994
14. NCHS. NHANES III-linked mortality file. Available at http://www.cdc.gov/ nchs/data-access/data-linkage/mortality/nhanes3- linkage.htm. Accessed 20 December 2008
15. NCHS. The Third National Health and Nutrition Examination Survey (NHANES III)-linked mortality file: matching methodology (2005). Available at http://www. cdc.gov/nchs/data/datalinkage/matching-methodology-nhanes3-final. pdf. Accessed 20 December 2008
16. Gunter EW, Lewis BG, Koncikowski SM. Laboratory Procedures Used for the Third National Health and Nutrition Examination Survey (NHANES III), 1988-1994. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Center for Environmental Health, Atlanta, GA, and National Center for Health Statistics, Hyattsville, MD. Available at http://www.cdc.gov/nchs/data/nhanes/ nhanes3/cdrom/nchs/manuals/ labman.pdf. Accessed 20 December 2008
17. Cox DR. Regression models and life tables. J Royal Stat Soc Ser B 1972;34:187-202
18. Analytic and Reporting Guidelines. The Third National Health and Nutrition Examination Survey, NHANES III (1988-94). October, 1996. Hyattsville, MD, National Center for Health Statistics Centers for Disease Control and Prevention. Available at http://www.cdc.gov/nchs/ data/nhanes/nhanes3/nh3gui. pdf. Accessed 1 October 2009
19. Hedblad B, Nilsson P, Engstrom G, Berglund G, Janzon L. Insulin resistance in non-diabetic subjects is associated with increased incidence of myocardial infarction and death. Diabet Med 2002;19:470-475 (Pubitemid 34639157)
20. Matsumoto K, Sera Y, Abe Y, Ueki Y, Tominaga T, Miyake S. Inflammation and insulin resistance are independently related to all-cause of death and cardiovascular events in Japanese patients with type 2 diabetes mellitus. Atherosclerosis 2002;169:317-321
21. Doehner W, von Haehling S, Anker SD. Insulin resistance in chronic heart failure. J Am Coll Cardiol 2008;52:239
22. Shinohara K, Shoji T, Emoto M, Tahara H, Koyama H, Ishimura E, Miki T, Tabata T, Nishizawa Y. Insulin resistance as an independent predictor of cardiovascular mortality in patients with end-stage renal disease. J Am Soc Nephrol 2002;13:1894-1900
23. Balkau B, Shipley M, Jarrett RJ, Pyorala K, Pyorala M, Forhan A, Eschwege E. High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study. Diabetes Care 1998;21:360-367
24. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Meigs JB, Bonadonna RC, Muggeo M. Insulin resistance as estimated by homeostasis model assessment predicts incident symptomatic cardiovascular disease in Caucasian subjects from the general population. Diabetes Care 2007;30:318-324
25. Ruge T, Lockton JA, Renstrom F, Lystig T, Sukonina V, Svensson MK, Eriksson JW. Acute hyperinsulinemia raises plasma interleukin-6 in both nondiabetic and type 2 diabetes mellitus subjects, and this effect is inversely associated with body mass index. Metabolism 2009;58:860-866